Epigral (BOM:543332) Interest Expense : ₹-735 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Epigral Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Epigral's interest expense for the three months ended in Mar. 2024 was ₹ -137 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-735 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Epigral's Operating Income for the three months ended in Mar. 2024 was ₹ 1,250 Mil. Epigral's Interest Expense for the three months ended in Mar. 2024 was ₹ -137 Mil. Epigral's Interest Coverage for the quarter that ended in Mar. 2024 was 9.13. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Epigral Interest Expense Historical Data

The historical data trend for Epigral's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral Interest Expense Chart

Epigral Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-78.02

-309.01

-442.70

-655.02

-734.89

Epigral Quarterly Data
	Mar18	Mar19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial											-189.88	-183.35	-212.73	-201.93	-136.87

Epigral Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-735 Mil.

Epigral (BOM:543332) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Epigral's Interest Expense for the three months ended in Mar. 2024 was ₹-137 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹1,250 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₹5,471 Mil.

Epigral's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	1249.656	/	-136.873
	=	9.13

The higher the ratio, the stronger the company's financial strength is.

Epigral (BOM:543332) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (BOM:543332) » Definitions » Interest Expense

Traded in Other Exchanges

EPIGRAL:India

Address

Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015

Website

https://www.meghmanifinechem.com

Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (BOM:543332) Headlines

No Headlines